1. Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?

   • Mahmoud Abbas
   • Sandra Steffens
   • Philipp Ivanyi

   Original Paper 10 May 2016 Article: 59

   

2. Rap2B promotes cell proliferation, migration and invasion in prostate cancer

   • Jiehui Di
   • Huan Cao
   • Junnian Zheng

   Original Paper 06 May 2016 Article: 58

   

3. Effects of polymorphisms in CYP2D6 and ABC transporters and side effects induced by gefitinib on the pharmacokinetics of the gefitinib metabolite, O-desmethyl gefitinib

   • Hiroyuki Kobayashi
   • Kazuhiro Sato
   • Masatomo Miura

   Original Paper 06 May 2016 Article: 57

   

4. ERAS protocol in laparoscopic surgery for colonic versus rectal carcinoma: are there differences in short-term outcomes?

   • Michał Pędziwiatr
   • Magdalena Pisarska
   • Andrzej Budzyński

   Original Paper Open access 06 May 2016 Article: 56

   

5. “No patient left behind”: an alternative to “the War on Cancer” metaphor

   • Bryan T. Oronsky
   • Corey A. Carter
   • Tony Reid

   Editorial 29 April 2016 Article: 55

6. Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer

   • Asta Bye
   • Nima Wesseltoft-Rao
   • Marianne J. Hjermstad

   Original Paper 27 April 2016 Article: 54